Defining the clinical course of multiple sclerosis

نویسندگان

  • Fred D. Lublin
  • Stephen C. Reingold
  • Jeffrey A. Cohen
  • Gary R. Cutter
  • Per Soelberg Sørensen
  • Alan J. Thompson
  • Jerry S. Wolinsky
  • Laura J. Balcer
  • Brenda Banwell
  • Frederik Barkhof
  • Bruce Bebo
  • Peter A. Calabresi
  • Michel Clanet
  • Giancarlo Comi
  • Robert J. Fox
  • Mark S. Freedman
  • Andrew D. Goodman
  • Matilde Inglese
  • Ludwig Kappos
  • Bernd C. Kieseier
  • John A. Lincoln
  • Catherine Lubetzki
  • Aaron E. Miller
  • Xavier Montalban
  • Paul W. O'Connor
  • John Petkau
  • Carlo Pozzilli
  • Richard A. Rudick
  • Maria Pia Sormani
  • Olaf Stüve
  • Emmanuelle Waubant
  • Chris H. Polman
چکیده

Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important for communication, prognostication, design and recruitment of clinical trials, and treatment decision-making. Standardized descriptions published in 1996 based on a survey of international MS experts provided purely clinical phenotypes based on data and consensus at that time, but imaging and biological correlates were lacking. Increased understanding of MS and its pathology, coupled with general concern that the original descriptors may not adequately reflect more recently identified clinical aspects of the disease, prompted a re-examination of MS disease phenotypes by the International Advisory Committee on Clinical Trials of MS. While imaging and biological markers that might provide objective criteria for separating clinical phenotypes are lacking, we propose refined descriptors that include consideration of disease activity (based on clinical relapse rate and imaging findings) and disease progression. Strategies for future research to better define phenotypes are also outlined.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Multiple Sclerosis in Iran

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS). This highlydisabling disorder is characterized by a variable clinical course. MS is a heterogeneous disease with acomplex pathology and significant social and economic impact. MS is associated with dysfunction ofparts of the nervous system which results in a range of signs and symptoms, ...

متن کامل

Review of New Methods of Diagnosis and Treatment of Multiple Sclerosis

Multiple sclerosis (MS) is a demyelinating process involving mainly the white matter of central nervous system. The clinical diagnosis generally rests on two features of the illness:  A. A history of fluctuations in the clinical course. B. A physical examination consistent with that of multiple lesionsjinllheiwhite matter o,f the central nervous system.  No specific laboratory test is cur...

متن کامل

دشواری‌های تشخیص اختلال دوقطبی در کودکان: از چارچوب تشخیصی رسمی تا معیارهای تشخیصی آشفتگی‌ شدید در تنظیم خلق

AbstractObjectives: Defining bipolar disorder in children is a topic of multiple debates. DSM-IV criteria can not cover all clinical phenotypes. This paper represents a literature review on this topic. Method: In a review study, data were collected through searching in relevant databases and assessing available texts. Results: Developmental processes may change clinical presentation of bipolar ...

متن کامل

Immunotherapy in Multiple Sclerosis (Ms)

Summary The immunosuppressive agent has changed the clinical course of MS. Mostly,this agent, like cyclophosphamide cyclosporine A., and X-Ray of the lymphoid organ, has a lot of side effects. It should only be used in the most severe from of MS among immunosuppressive agents, Azathioprin has been used most frequently in spite of the fact that it is not very effective compared with other immun...

متن کامل

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis

Introduction: An impaired sense of smell has a remarkable impact on the quality of life. It is seen in a variety of neurodegenerative diseases such as Parkinson disease. In this study, we assessed the olfactory function in patients with Multiple Sclerosis (MS) by Sniff Magnitude Test (SMT).  Methods: A cross-sectional study was conducted on 48 patients with MS. A questionnaire, including demog...

متن کامل

Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis

Background: Statins, widely used cholesterol-lowering agents, have also been demonstrated to have anti-inflammatory and immunomdulatory effects. Objective: To evaluate the effects of atorvastatin in combination with Interferon-β in the treatment of multiple sclerosis (MS) in a randomized controlled clinical trial. Methods: Multiple sclerosis patients were randomized independently, in a double b...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 83  شماره 

صفحات  -

تاریخ انتشار 2014